EudraCT 2009‐013120‐23.

Trial name or title	Efficacité et tolérance du LBC 45 dans la dermite séborrhéique du cuir chevelu
Methods	This is a randomised, controlled, double‐blind, parallel group, phase II study Initial estimate of the duration of the trial: 70 days
Participants	18 years or older with seborrhoeic dermatitis of the scalp of moderate to severe intensity Disease for at least 2 months
Interventions	Lithium gluconate gel 8/100 g/g Placebo gel
Outcomes	Primary outcome/s of the trial The sum of erythema and scaling scores at day 56 Secondary outcome/s of the trial None mentioned
Starting date	Entered into database: August 2009
Contact information	LABCATAL, France
Notes	Ongoing study. Database accessed on 17 December 2012